Victrex EBITDA 2019-2024 | VTXPF
Victrex ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Victrex Annual EBITDA
(Millions of US $) |
| 2024 |
$88 |
| 2023 |
$116 |
| 2022 |
$141 |
| 2021 |
$158 |
| 2020 |
$108 |
| 2019 |
$155 |
| 2018 |
$195 |
| 2016 |
$359 |
| 2015 |
$407 |
| 2014 |
$418 |
Victrex Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
|
| 2023-09-30 |
|
| 2023-03-31 |
|
| 2022-09-30 |
|
| 2022-03-31 |
|
| 2021-09-30 |
|
| 2021-03-31 |
|
| 2020-09-30 |
|
| 2020-03-31 |
|
| 2019-09-30 |
|
| 2019-03-31 |
|
| 2018-09-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Plastics |
$1.092B |
$0.369B |
|
Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom.
|
